搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
vtgn
/
财务摘要
Vistagen Therapeutics Inc
VTGN
添加自选
0.368
USD
+0.117
+46.61%
收盘 09-23 16:00(美东)
15.10M
总市值
亏损
市盈率 TTM
盘后交易 19:34 (美东)
0.350
USD
-0.025
-6.67%
Vistagen Therapeutics Inc
0.368
+0.117
+46.61%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
VTGN 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Vistagen Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
15.10M
股息TTM
0.00
市盈率 TTM
-0.19
每股收益TTM
-1.89
营业收入
1.27M
净利润
-51.42M
净资产收益率
-101.55%
总资产收益率
-85.21%
Vistagen Therapeutics Inc 财报日历
最新发布
8月 14, 2026
每股收益 / 预测值
-0.30
/-0.37
营业收入 / 预测值
1.48M
/250.00K
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2027Q1
FY2026Q4
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
财务指标
每股收益
35.87%
-0.30
11.01%
-0.38
2.46%
-0.45
-28.37%
-0.54
-34.80%
-0.47
-38.48%
-0.43
-112.32%
-0.46
35.50%
-0.42
62.52%
-0.35
99.41%
-0.31
84.74%
-0.22
--
-0.66
--
-0.94
--
-52.71
--
-1.42
--
-5.41
--
--
--
--
--
--
--
--
营业收入
504.92%
1.48M
--
465.00K
29.49%
303.00K
40.98%
258.00K
190.48%
244.00K
--
--
-43.12%
234.00K
-34.10%
183.00K
-52.70%
84.00K
12.36%
197.30K
129.06%
411.40K
131.11%
277.70K
-42.73%
177.60K
351.41%
175.60K
-49.82%
179.60K
-349.30%
-892.50K
-12.43%
310.10K
-91.20%
38.90K
14.13%
357.90K
7.19%
358.00K
净利润
13.68%
-13.03M
-19.35%
-16.27M
-34.14%
-18.90M
-49.81%
-19.42M
-40.64%
-15.10M
-43.20%
-13.63M
-121.88%
-14.09M
-96.75%
-12.96M
-55.48%
-10.73M
22.13%
-9.52M
34.95%
-6.35M
62.32%
-6.59M
65.09%
-6.90M
26.73%
-12.23M
9.14%
-9.76M
-32.75%
-17.48M
-143.96%
-19.78M
43.54%
-16.69M
-90.07%
-10.74M
-261.31%
-13.17M
利润率
85.73%
-882.79%
--
-3499.78%
-3.59%
-6237.29%
-6.26%
-7525.97%
51.58%
-6186.48%
--
--
-290.09%
-6020.94%
-198.56%
-7082.51%
-228.73%
-12777.38%
30.69%
-4825.85%
71.60%
-1543.46%
--
-2372.24%
--
-3886.88%
--
-6962.98%
--
-5434.97%
--
--
--
--
--
--
--
--
--
--
毛利率
0.00%
100.00%
--
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
--
--
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
--
--
资产负债率
-100.00%
0.00%
--
0.20%
--
0.58%
--
0.81%
--
1.35%
--
--
--
--
--
--
--
--
-100.00%
0.00%
-99.58%
0.01%
--
0.02%
--
5.27%
--
0.54%
--
1.44%
--
1.82%
--
--
--
--
--
--
--
--
利润表
营业收入
504.92%
1.48M
--
465.00K
29.49%
303.00K
40.98%
258.00K
190.48%
244.00K
--
--
-43.12%
234.00K
-34.10%
183.00K
-52.70%
84.00K
12.36%
197.30K
129.06%
411.40K
131.11%
277.70K
-42.73%
177.60K
351.41%
175.60K
-49.82%
179.60K
-349.30%
-892.50K
-12.43%
310.10K
-91.20%
38.90K
14.13%
357.90K
7.19%
358.00K
营业利润
15.54%
-13.35M
-15.33%
-16.72M
-29.27%
-19.55M
-40.95%
-20.05M
-30.28%
-15.80M
-27.61%
-14.49M
-91.78%
-15.12M
-109.83%
-14.23M
-73.35%
-12.13M
7.19%
-11.36M
19.28%
-7.88M
61.23%
-6.78M
64.61%
-7.00M
26.68%
-12.24M
7.34%
-9.77M
-36.64%
-17.49M
-155.26%
-19.77M
-168.42%
-16.69M
-98.90%
-10.54M
-288.61%
-12.80M
净利润
13.68%
-13.03M
-19.35%
-16.27M
-34.14%
-18.90M
-49.81%
-19.42M
-40.64%
-15.10M
-43.20%
-13.63M
-121.88%
-14.09M
-96.75%
-12.96M
-55.48%
-10.73M
22.13%
-9.52M
34.95%
-6.35M
62.32%
-6.59M
65.09%
-6.90M
26.73%
-12.23M
9.14%
-9.76M
-32.75%
-17.48M
-143.96%
-19.78M
43.54%
-16.69M
-90.07%
-10.74M
-261.31%
-13.17M
资产负债表
流动资产
-48.57%
34.31M
-42.81%
46.94M
-29.68%
63.24M
-21.02%
78.93M
-39.81%
66.72M
-31.98%
82.08M
-29.80%
89.94M
155.78%
99.95M
857.25%
110.84M
589.26%
120.67M
391.66%
128.11M
5.86%
39.08M
-78.95%
11.58M
-75.34%
17.51M
-69.97%
26.06M
-61.72%
36.91M
-44.91%
54.99M
-31.81%
71.00M
-17.36%
86.77M
503.79%
96.44M
流动负债总额
0.33%
11.19M
1.45%
12.79M
40.62%
13.53M
81.36%
13.64M
78.88%
11.15M
146.18%
12.61M
131.02%
9.62M
158.57%
7.52M
54.01%
6.24M
12.16%
5.12M
-2.87%
4.16M
-51.87%
2.91M
-54.64%
4.05M
-20.78%
4.57M
-33.23%
4.29M
-23.59%
6.05M
42.43%
8.93M
37.62%
5.77M
115.38%
6.42M
139.63%
7.91M
总资产
-48.15%
35.74M
-42.42%
48.56M
-29.52%
65.06M
-21.04%
80.93M
-39.30%
68.92M
-31.79%
84.34M
-29.57%
92.31M
142.91%
102.50M
655.36%
113.55M
486.33%
123.65M
341.18%
131.07M
3.67%
42.20M
-74.40%
15.03M
-71.75%
21.09M
-67.19%
29.71M
-59.50%
40.70M
-43.48%
58.73M
-31.07%
74.64M
-17.15%
90.54M
395.79%
100.50M
总负债
-7.43%
11.26M
-6.50%
13.04M
26.38%
14.14M
53.22%
14.59M
39.04%
12.16M
48.94%
13.95M
43.71%
11.19M
45.36%
9.52M
6.86%
8.74M
3.97%
9.37M
-13.85%
7.78M
-40.97%
6.55M
-35.43%
8.18M
-9.26%
9.01M
-14.43%
9.03M
-44.07%
11.10M
-30.71%
12.67M
-39.10%
9.93M
-31.71%
10.56M
23.63%
19.84M
总权益
-56.87%
24.48M
-49.54%
35.52M
-37.23%
50.92M
-28.65%
66.34M
-45.84%
56.77M
-38.41%
70.39M
-34.20%
81.12M
160.83%
92.97M
1430.19%
104.80M
846.08%
114.29M
496.31%
123.28M
20.40%
35.65M
-85.13%
6.85M
-81.33%
12.08M
-74.15%
20.67M
-63.30%
29.61M
-46.21%
46.05M
-29.64%
64.72M
-14.75%
79.98M
1810.19%
80.66M
现金流量表
经营净额
21.96%
-14.71M
-61.00%
-16.20M
-71.51%
-17.63M
-26.39%
-13.76M
-73.39%
-18.85M
-39.81%
-10.06M
-126.66%
-10.28M
-75.88%
-10.89M
-37.74%
-10.87M
3.69%
-7.20M
54.34%
-4.54M
62.12%
-6.19M
50.58%
-7.89M
52.06%
-7.47M
17.54%
-9.93M
-42.72%
-16.34M
-158.68%
-15.97M
-195.13%
-15.59M
-141.46%
-12.05M
-1240.74%
-11.45M
投资净额
100.00%
0.00
-118.79%
-99.00K
124.64%
104.00K
98.79%
-94.00K
85.59%
-788.00K
1936.24%
527.00K
-1206.50%
-422.00K
--
-7.79M
--
-5.47M
94.57%
-28.70K
-158.40%
-32.30K
100.00%
0.00
100.00%
0.00
-528200.00%
-528.30K
-12600.00%
-12.50K
51.68%
-24.40K
-16.81%
-175.10K
99.61%
-100.00
100.07%
100.00
48.89%
-50.50K
融资净额
-38.91%
909.00K
-114.51%
-283.00K
80.36%
2.11M
--
27.65M
1590.91%
1.49M
1262.69%
1.95M
-98.75%
1.17M
-100.00%
0.00
-89.95%
88.00K
57.91%
-167.80K
30852.55%
93.52M
10332.25%
34.18M
16020.00%
875.60K
-1782.28%
-398.70K
-114.35%
-304.10K
-104.54%
-334.00K
-100.55%
-5.50K
-99.42%
23.70K
-97.75%
2.12M
-43.24%
7.35M
常见问题
Vistagen Therapeutics Inc的总收入是多少?
根据Vistagen Therapeutics Inc的FY2026财报,总收入达到了1.27M(同比变化486.00K)。
Vistagen Therapeutics Inc的流动资产是多少?
根据Vistagen Therapeutics Inc的FY2026财报,流动资产为46.94M(同比变化-42.81)。
Vistagen Therapeutics Inc的总资产是多少?
根据Vistagen Therapeutics Inc的FY2026财报,Vistagen Therapeutics Inc的总资产为48.56M(同比变化-42.42)。
Vistagen Therapeutics Inc的总负债是多少?
根据Vistagen Therapeutics Inc的FY2026财报,Vistagen Therapeutics Inc的总负债为13.04M(同比变化-6.50)。
Vistagen Therapeutics Inc的总权益是多少?
根据Vistagen Therapeutics Inc的FY2026财报,Vistagen Therapeutics Inc的总权益为35.52M(同比变化-49.54)。
Vistagen Therapeutics Inc的净营业收入是多少?
根据Vistagen Therapeutics Inc的FY2026财报,Vistagen Therapeutics Inc的净营业收入为-72.13M(同比变化-28.86)。
Vistagen Therapeutics Inc的净投资是多少?
根据Vistagen Therapeutics Inc的FY2026财报,Vistagen Therapeutics Inc的净投资为-877.00K(同比变化93.33)。
Vistagen Therapeutics Inc的净融资是多少?
根据Vistagen Therapeutics Inc的FY2026财报,Vistagen Therapeutics Inc的净融资为30.97M(同比变化864.83)。
Vistagen Therapeutics Inc的每股收益(EPS)是多少?
根据Vistagen Therapeutics Inc的FY2026财报,每股收益(EPS)为-1.83(同比变化-9.91)。
Vistagen Therapeutics Inc的净利润是多少?
根据Vistagen Therapeutics Inc的FY2026财报,净利润为-69.69M(同比变化-35.53)。
Vistagen Therapeutics Inc的净利润率是多少?
根据Vistagen Therapeutics Inc的FY2026财报,净利润率为-5491.33(同比变化48.10)。
Vistagen Therapeutics Inc的股东权益回报率(ROE)是多少?
根据Vistagen Therapeutics Inc的FY2026财报,股东权益回报率(ROE)为-131.59(同比变化-136.32)。
Vistagen Therapeutics Inc的资产回报率(ROA)是多少?
根据Vistagen Therapeutics Inc的FY2026财报,资产回报率(ROA)为-104.86(同比变化-112.10)。
Vistagen Therapeutics Inc的营业利润是多少?
根据Vistagen Therapeutics Inc的FY2026财报,营业利润为-72.13M(同比变化-28.86)。